相关实验视频
Updated: Jan 8, 2026

08:07
Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
Published on: April 12, 2019
7.6K
软骨肉瘤:临床行为,分子机制和新兴治疗策略
Mark Agulnik1, Breelyn A Wilky2, Steven W Thorpe Facs3
1Department of Medicine, Division of Medical Oncology, Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA.
Critical reviews in oncology/hematology
|December 14, 2025
概括
罕见的骨癌 - - 冠状肉瘤 - - 对晚期癌症的治疗方法有限. 研究确定了像IDH1/2突变这样的关键分子驱动因素,为新的向疗法和免疫疗法提供了希望.
科学领域:
- 整形外科 整形外科 整形外科
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 冠状肉瘤是第二个最常见的原发性恶性骨瘤,其5年生存率为70-75%.
- 高度和攻击性亚型的预后不好,需要更好的治疗选择.
- 目前的标准治疗是手术切除,但对于不可切除或转移性疾病缺乏有效的治疗方法.
研究的目的:
- 审查冠状腺癌亚型,诊断,预后和分子变化.
- 讨论现有和新兴的治疗策略,以治疗晚期软骨肉瘤.
- 突出针对性疗法和免疫疗法的临床试验.
主要方法:
- 对临床前研究和患者瘤样本分析的审查.
- 探索分子机制,包括IDH1/2和TP53突变,信号通路和PD-L1表达.
- 讨论正在进行的新疗法临床试验.
主要成果:
- 确定了关键的分子驱动因素:IDH1/2突变,TP53突变,信号通路过活化和PD-L1表达.
- 强调了对于晚期软骨肉瘤进行外科手术以外的有效治疗的需要.
- 强调了向疗法和免疫疗法的潜力.
结论:
- 抑制IDH1/2和激酶的向疗法显示出有前途.
- 免疫疗法和其他新的方法,如死亡受体5激动体正在研究中.
- 进一步的研究和临床试验对于推进软骨肉瘤治疗至关重要.
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K

